Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMercia Asset Regulatory News (MERC)

Share Price Information for Mercia Asset (MERC)

Share Price is delayed by 15 minutes
Get Live Data
29.25    0.00 (0.00%)
Bid:
28.50
Ask:
30.00
Spread: 1.50 (5.263%)
Market Cap: £121.72m
MERC Live PriceLast checked at - London Stock Exchange

Intraday Mercia Asset Share Chart

Statement re Major Interest i

24 Jul 2008 17:06

RNS Number : 8480Z
Merchant Securities PLC
24 July 2008
 



Form TR-1 with annex. FSA Version 2.1 updated April 2007

For filings with the FSA include the annex

For filings with issuer exclude the annex 

TR-1: Notifications of Major Interests in Shares

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached:

Merchant Securities PLC

2. Reason for notification (yes/no)

An acquisition or disposal of voting rights

Yes 

An acquisition or disposal of financial instruments which may result in the acquisition of shares already issued to which voting rights are attached 

No

An event changing the breakdown of voting rights

No

Other (please specify):______________

N/A

3. Full name of person(s) subject to notification obligation:

Dom Maklerski IDM Spolka Akcyjna ("IDMSA")

4. Full name of shareholder(s) (if different from 3):

Pershing Nominees Limited

5. Date of transaction (and date on which the threshold is crossed or reached if different):

22 July 2008

6. Date on which issuer notified:

22 July 2008

7. Threshold(s) that is/are crossed or reached:

17.06%

8: Notified Details

A: Voting rights attached to shares

Class/type of shares

If possible use ISIN code

Situation previous to the triggering transaction

Resulting situation after the triggering transaction

Number of shares

Number of voting rights

Number of shares

Number of voting rights

Percentage of voting rights

Direct

Indirect

Direct

Indirect

Ordinary NIL NIL 8,000,000 8,000,000 NIL 17.06% NIL

shares: 

GB00B1FRQG03

B: Financial Instruments

Resulting situation after the triggering transaction

Type of financial instrument

Expiration date

Exercise/ conversion period/date 

No. of voting rights that may be acquired (if the instrument exercised/converted)

Percentage of voting rights

NIL

Total (A+B)

Number of voting rights

Percentage of voting rights

8,000,000

17.06%

9. Chain of controlled undertakings through which the voting rights and /or the financial instruments are effectively held, if applicable:

8,000,000 shares are held by Pershing Nominees Limited. Shares are under the control of Dom Maklerski IDM Spolka Akcyjna ("IDMSA")

Proxy Voting:

10. Name of proxy holder:

N/A

11. Number of voting rights proxy holder will cease to hold:

N/A

12. Date on which proxy holder will cease to hold voting rights:

N/A

13. Additional information:

NIL

14 Contact name:

Lukasz Jagiello

15. Contact telephone name:

+ 48 22 489 94 65, mob. +48 602 636 419

For notes on how to complete form TR-1 please see the FSA website. 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLBLGDRDGDGGIS
Date   Source Headline
18th Sep 201711:05 amRNSResult of AGM
18th Sep 20177:00 amRNSAGM statement
21st Aug 20177:00 amRNS£2.0m investment into Oxford Genetics
2nd Aug 20177:00 amRNSBoard Change
25th Jul 20177:00 amRNSGrant Options & PDMR Dealings
21st Jul 20177:00 amRNSPublication of Annual Report
13th Jul 20177:00 amRNSMercia invests additional £2.0million into nDreams
3rd Jul 20177:00 amRNSPreliminary results
21st Jun 20177:00 amRNSInvestment into Impression Tech & Sector Update
6th Jun 20177:00 amRNSFurther investment into Oxford Genetics
3rd May 20177:00 amRNSNotice of Preliminary Results
22nd Feb 20177:00 amRNSTwo major contracts for Northern Powerhouse Funds
17th Feb 201712:00 pmRNSNotification of Major Interest in Shares
16th Feb 201710:43 amRNSResult of General Meeting & Completion of Placing
31st Jan 20172:40 pmRNSPlacing of new Ordinary Shares to raise c.£40.0m
26th Jan 20177:00 amRNSNotice of Mercia Annual Gala Dinner
18th Jan 20177:00 amRNSNew Direct Investment in Faradion Limited
16th Dec 20167:00 amRNSSale of Allinea Software Limited to ARM
16th Nov 20167:00 amRNS£1m invested in nDreams as part of £2m syndication
10th Nov 20167:00 amRNSHalf Year Results
28th Oct 20167:00 amRNSNotice of Results
27th Oct 20167:00 amRNSInvestment in Oxford Genetics Limited
19th Oct 20167:00 amRNSWarwick Audio Technologies strengthens Board
11th Oct 20167:00 amRNSDigital & Digital Entertainment Portfolio Update
5th Oct 20167:00 amRNSCapital Markets Event
27th Sep 20167:00 amRNSInvestment into innovative healthcare - Medherant
19th Sep 201610:36 amRNSResult of AGM
26th Aug 20167:00 amRNSDirector/PDMR Shareholdings
29th Jul 20167:00 amRNSPublication of Annual Report
28th Jul 20167:00 amRNSGrant Options & PDMR Dealings
26th Jul 20168:30 amRNSRe. Admission to AIM of Concepta PLC
21st Jul 20167:00 amRNSnDreams launches The Assembly for Oculus RIFT
7th Jul 20167:00 amRNSAcquisition, Placing & Open Offer, Change of Name
7th Jul 20167:00 amRNSFundraising & AIM Admission of Direct Investment
30th Jun 20167:00 amRNSPreliminary Results
20th Jun 20167:00 amRNSFour New University Partnerships
1st Jun 20167:00 amRNSNotice of Preliminary Results
26th May 20167:00 amRNSBoard Changes
20th May 20167:00 amRNSMercia's nDreams signs Google VR app deal
9th May 20167:00 amRNSFirst Direct Investment via Enterprise Ventures
17th Mar 20163:30 pmRNSNotification of Major Interest in Shares
17th Mar 20167:00 amRNSNew Direct Investment
10th Mar 20167:02 amRNSAcquisition of Enterprise Ventures
21st Jan 20167:00 amRNSNotice of Mercia Fund Management AGM
15th Dec 20157:00 amRNSThree additional university partnerships
3rd Dec 20157:00 amRNSHalf Yearly Report
10th Nov 20157:00 amRNSNotice of Results
5th Nov 20157:00 amRNSInvests in Edge Case, alongside China's Seasun
27th Oct 20157:00 amRNSNew office and university partnerships in Scotland
22nd Oct 20157:00 amRNS£1.2m investment in Smart Antenna Technologies

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.